Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-15-000602
Filing Date
2015-02-11
Accepted
2015-02-11 11:02:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 CYMABAY THERAPEUTICS, INC. p15-0382sc13g.htm SC 13G 53951
  Complete submission text file 0000902664-15-000602.txt   55626
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

EIN.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87950 | Film No.: 15597523
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 7TH AVENUE, 11TH FLOOR NEW YORK NY 10106
Business Address 888 7TH AVENUE, 11TH FLOOR NEW YORK NY 10106 212-295-6200
Lombard Odier Asset Management (USA) Corp (Filed by) CIK: 0001491719 (see all company filings)

EIN.: 061603711 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G